These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20853931)

  • 1. Clinical outcomes of an integrated treatment for depression and substance use disorders.
    Lydecker KP; Tate SR; Cummins KM; McQuaid J; Granholm E; Brown SA
    Psychol Addict Behav; 2010 Sep; 24(3):453-65. PubMed ID: 20853931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action in integrated cognitive-behavioral treatment versus twelve-step facilitation for substance-dependent adults with comorbid major depression.
    Glasner-Edwards S; Tate SR; McQuaid JR; Cummins K; Granholm E; Brown SA
    J Stud Alcohol Drugs; 2007 Sep; 68(5):663-72. PubMed ID: 17690799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated cognitive behavioral therapy versus twelve-step facilitation therapy for substance-dependent adults with depressive disorders.
    Brown SA; Glasner-Edwards SV; Tate SR; McQuaid JR; Chalekian J; Granholm E
    J Psychoactive Drugs; 2006 Dec; 38(4):449-60. PubMed ID: 17373561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological functioning and outcomes of treatment for co-occurring depression and substance use disorders.
    Granholm E; Tate SR; Link PC; Lydecker KP; Cummins KM; McQuaid J; Shriver C; Brown SA
    Am J Drug Alcohol Abuse; 2011 Jul; 37(4):240-9. PubMed ID: 21517712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediational relations between 12-Step attendance, depression and substance use in patients with comorbid substance dependence and major depression.
    Worley MJ; Tate SR; Brown SA
    Addiction; 2012 Nov; 107(11):1974-83. PubMed ID: 22578037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12-step affiliation and attendance following treatment for comorbid substance dependence and depression: a latent growth curve mediation model.
    Worley MJ; Tate SR; McQuaid JR; Granholm EL; Brown SA
    Subst Abus; 2013; 34(1):43-50. PubMed ID: 23327503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of treatment retention for substance-dependent adults with co-occurring depression.
    Tate SR; Mrnak-Meyer J; Shriver CL; Atkinson JH; Robinson SK; Brown SA
    Am J Addict; 2011; 20(4):357-65. PubMed ID: 21679267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequenced versus coordinated treatment for adolescents with comorbid depressive and substance use disorders.
    Rohde P; Waldron HB; Turner CW; Brody J; Jorgensen J
    J Consult Clin Psychol; 2014 Apr; 82(2):342-8. PubMed ID: 24491069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttraumatic stress disorder's role in integrated substance dependence and depression treatment outcomes.
    Norman SB; Tate SR; Wilkins KC; Cummins K; Brown SA
    J Subst Abuse Treat; 2010 Jun; 38(4):346-55. PubMed ID: 20363091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The moderating effects of group cognitive-behavioral therapy for depression among substance users.
    Hunter SB; Witkiewitz K; Watkins KE; Paddock SM; Hepner KA
    Psychol Addict Behav; 2012 Dec; 26(4):906-16. PubMed ID: 22564202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated Cognitive Behavioral Therapy Versus Cognitive Processing Therapy for Adults With Depression, Substance Use Disorder, and Trauma.
    Haller M; Norman SB; Cummins K; Trim RS; Xu X; Cui R; Allard CB; Brown SA; Tate SR
    J Subst Abuse Treat; 2016 Mar; 62():38-48. PubMed ID: 26718130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot randomized clinical trial testing integrated 12-Step facilitation (iTSF) treatment for adolescent substance use disorder.
    Kelly JF; Kaminer Y; Kahler CW; Hoeppner B; Yeterian J; Cristello JV; Timko C
    Addiction; 2017 Dec; 112(12):2155-2166. PubMed ID: 28742932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.
    Coughlin LN; Pfeiffer P; Ganoczy D; Lin LA
    Am J Psychiatry; 2021 May; 178(5):414-423. PubMed ID: 33115247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsomatic treatment of depression.
    Sherrill JT; Kovacs M
    Child Adolesc Psychiatr Clin N Am; 2002 Jul; 11(3):579-93. PubMed ID: 12222084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductions in HIV risk behaviors among depressed drug injectors.
    Stein MD; Anderson BJ; Solomon DA; Herman DS; Ramsey SE; Brown RA; Miller IW
    Am J Drug Alcohol Abuse; 2005; 31(3):417-32. PubMed ID: 16161727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does initial treatment focus influence outcomes for depressed substance abusers?
    Drapkin ML; Tate SR; McQuaid JR; Brown SA
    J Subst Abuse Treat; 2008 Oct; 35(3):343-50. PubMed ID: 18295436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated treatment of comorbid depression and substance use disorders.
    Charney DA; Paraherakis AM; Gill KJ
    J Clin Psychiatry; 2001 Sep; 62(9):672-7. PubMed ID: 11681761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic physical health problems moderate changes in depression and substance use among dual diagnosed individuals during and after treatment.
    Cui R; Tate SR; Cummins K; Skidmore JR; Brown SA
    Subst Use Misuse; 2015 Jan; 50(2):174-83. PubMed ID: 25290658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.
    Nunes EV; Levin FR
    JAMA; 2004 Apr; 291(15):1887-96. PubMed ID: 15100209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal associations between depression and problematic substance use in the Youth Partners in Care study.
    McKowen JW; Tompson MC; Brown TA; Asarnow JR
    J Clin Child Adolesc Psychol; 2013; 42(5):669-80. PubMed ID: 23368836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.